Genetically engineered yeast makes medicinal plant products

Montaño López, José; Avalos, José L.

doi:10.1038/d41586-020-02461-8

NEWS AND VIEWS
02 September 2020

Genetically engineered yeast makes medicinal plant products

Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.

José Montaño López⁰ &
José L. Avalos¹

José Montaño López
1. José Montaño López is in the Department of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, USA.
View author publications

You can also search for this author in PubMed Google Scholar
José L. Avalos
1. José L. Avalos is in the Department of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, USA, and in the Andlinger Center for Energy and the Environment, the Department of Molecular Biology and the Princeton Environmental Institute, Princeton University.
View author publications

You can also search for this author in PubMed Google Scholar

Access through your institution

Buy or subscribe

In Homer’s Odyssey, the sorceress Circe slipped Odysseus’ companions a poison to induce amnesia and hallucinations. Scientists have speculated¹ that Circe’s concoction contained the plant jimsonweed (Datura stramonium), which is rich in drugs called tropane alkaloids that are used to treat asthma, influenza symptoms and pain, and that can induce hallucinogenic and other psychotropic effects. Tropane alkaloids, like most other plant natural products, are still typically extracted from natural sources, but this approach has many pitfalls. For instance, vulnerability to weather and market fluctuations can limit access for both patients and researchers, and extraction can be environmentally harmful²^,³. In addition, plants typically contain very low levels of these active ingredients. Writing in Nature, Srinivasan and Smolke⁴ report an alternative way to make tropane alkaloids that could relieve these limitations — using engineered strains of the baker’s yeast Saccharomyces cerevisiae.

Access options

Access through your institution

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 585, 504-505 (2020)

doi: https://doi.org/10.1038/d41586-020-02461-8

References

Kaplan, M. Science Of The Magical: From the Holy Grail to Love Potions to Superpowers (Simon & Schuster, 2015).
Google Scholar
Cravens, A., Payne, J. & Smolke, C. D. Nature Commun. 10, 2142 (2019).
Article PubMed Google Scholar
Li, S., Li, Y. & Smolke, C. D. Nature Chem. 10, 395–404 (2018).
Article PubMed Google Scholar
Srinivasan, P. & Smolke, C. D. Nature 585, 614–619 (2020).
Article Google Scholar
Ro, D.-K. et al. Nature 440, 940–943 (2006).
Article PubMed Google Scholar
Ajikumar, P. K. et al. Science 330, 70–74 (2010).
Article PubMed Google Scholar
Brown, S., Clastre, M., Courdavault, V. & O’Connor, S. E. Proc. Natl Acad. Sci. USA 112, 3205–3210 (2015).
Article PubMed Google Scholar
Kohnen-Johannsen, K. L. & Kayser, O. Molecules 24, 796 (2019).
Article Google Scholar
Kukula-Koch, W. A. & Widelski, J. in Pharmacognosy: Fundamentals, Applications and Strategy (eds Badal, S. & Delgoda, R.) 163–198 (Elsevier, 2017).
Google Scholar
Grynkiewicz, G. & Gadzikowska, M. Pharmacol. Rep. 60, 439–463 (2008).
PubMed Google Scholar
Hammer, S. K. & Avalos, J. L. Nature Chem. Biol. 13, 823–832 (2017).
Article PubMed Google Scholar
Srinivasan, P. & Smolke, C. D. Nature Commun. 10, 3634 (2019).
Article PubMed Google Scholar